Form 8-K - Current report:
SEC Accession No. 0001117480-22-000002
Filing Date
2022-02-01
Accepted
2022-01-31 19:21:17
Documents
12
Period of Report
2022-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K cmrx-20220131.htm   iXBRL 8-K 46831
  Complete submission text file 0001117480-22-000002.txt   189064

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmrx-20220131.xsd EX-101.SCH 1902
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmrx-20220131_lab.xml EX-101.LAB 24849
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmrx-20220131_pre.xml EX-101.PRE 13046
6 EXTRACTED XBRL INSTANCE DOCUMENT cmrx-20220131_htm.xml XML 11819
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

EIN.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35867 | Film No.: 22576102
SIC: 2834 Pharmaceutical Preparations